Min-Shi Lee | Infectious Diseases | Innovative Research Award

Published on by Health Scientists

Innovative Research Award

Min-Shi Lee — National Health Research Institutes, Taiwan

Min-Shi Lee
Affiliation National Health Research Institutes
Country Taiwan
Scopus ID 26659600600
Documents 68
Citations 2,172
h-index 29
Subject Area Infectious Diseases
Event Health Scientists Awards
ORCID 0000-0001-5914-3370

Min-Shi Lee is an infectious-disease researcher at the National Health Research Institutes in Taiwan whose work spans epidemiology, virology, vaccinology, assay development, and bioinformatics. Her publication record addresses enteroviruses, influenza viruses, vaccine development, surveillance, viral characterization, and pandemic preparedness. Research contributions include studies of EV-A71 epidemiology, enterovirus surveillance networks, influenza vaccine viruses, recombinant hemagglutinin immunogenicity, and genomic approaches for identifying recombinant enteroviruses. Recent work has examined monoclonal antibodies for monitoring EV-A71 vaccine potency. Collectively, these studies connect laboratory investigation with surveillance and translational vaccine research relevant to infectious-disease prevention, preparedness, and public-health decision-making nationally and internationally.

Abstract

Min-Shi Lee is an infectious-disease researcher at the National Health Research Institutes in Taiwan whose work spans epidemiology, virology, vaccinology, assay development, and bioinformatics. Her publication record addresses enteroviruses, influenza viruses, vaccine development, surveillance, viral characterization, and pandemic preparedness. Research contributions include studies of EV-A71 epidemiology, enterovirus surveillance networks, influenza vaccine viruses, recombinant hemagglutinin immunogenicity, and genomic approaches for identifying recombinant enteroviruses. Recent work has examined monoclonal antibodies for monitoring EV-A71 vaccine potency. Collectively, these studies connect laboratory investigation with surveillance and translational vaccine research relevant to infectious-disease prevention, preparedness, and public-health decision-making nationally and internationally in practice and policy.

Keywords

Min-Shi Lee’s publication-based keywords include enterovirus 71, EV-A71, enterovirus surveillance, influenza H5N1, influenza H5N2, influenza H7N9, vaccine development, vaccine potency, immunogenicity, recombinant hemagglutinin, monoclonal antibodies, viral genomics, genome sequencing, recombinant enteroviruses, epidemiology, virology, vaccinology, assay development, pandemic preparedness, molecular surveillance, seroprevalence, antiviral research, vaccine viruses, emerging viruses, and infectious-disease prevention.

Introduction

Min-Shi Lee’s research career at the National Health Research Institutes centers on emerging infectious viruses and vaccine science. Institutional records identify expertise in epidemiology, vaccinology, virology, infectious diseases, vaccine development, assay development, and bioinformatics. Her work combines epidemiological surveillance with laboratory investigation to address emerging viral threats and practice. [2]

Research Profile

Min-Shi Lee has worked with the NHRI since 2005 and currently serves as an investigator in its National Institute of Infectious Diseases and Vaccinology. Her professional background includes epidemiology and vaccine research, while institutional activities emphasize emerging viruses, influenza, enteroviruses, surveillance, and collaborative infectious-disease research across Asia-Pacific partnerships across regions. [2]

Research Contributions

Min-Shi Lee has contributed to research on EV-A71 surveillance and vaccine evaluation, influenza H5N1, H5N2, and H7N9 vaccine development, and molecular characterization of enteroviruses. Her publications also address recombinant viral vaccine production, immunogenicity, antibody development, and genomic sequencing, illustrating an integrated approach linking virology, epidemiology, laboratory methods, and translational vaccinology. [3] [4] [5]

Publications

Min-Shi Lee’s indexed publications include studies of EV-A71 vaccine licensure challenges, influenza H5N1 vaccine-virus adaptation, H7N9 recombinant hemagglutinin immunogenicity, enterovirus surveillance, recombinant-enterovirus genome sequencing, and EV-A71 monoclonal antibodies. Representative articles have appeared in PLOS Neglected Tropical Diseases, PLOS ONE, Vaccine, Microbiology Spectrum, and related infectious-disease journals of interest. [3] [4] [5]

Research Impact

Min-Shi Lee’s research impact is reflected in a substantial indexed publication record and in collaborative surveillance and vaccine-development studies. Her work has supported understanding of enterovirus epidemiology, influenza vaccine preparedness, and laboratory methods for viral monitoring. The research also contributes evidence relevant to vaccine potency assessment and emerging-virus preparedness activities. [1] [2]

Award Suitability

Min-Shi Lee’s profile is suitable for an innovative research recognition focused on infectious diseases because her work connects epidemiological surveillance, virology, vaccine development, and translational assay research. Her publications demonstrate sustained engagement with emerging viral threats and collaborative scientific programs, providing a basis for recognizing contributions to infectious-disease research. [2] [3] [4]

Conclusion

Min-Shi Lee represents a research profile focused on infectious diseases, virology, epidemiology, and vaccinology, with publications spanning enteroviruses, influenza viruses, surveillance, vaccine development, and molecular methods. Her work demonstrates continuity between public-health questions and laboratory research, while collaborative studies extend its relevance to surveillance, vaccine preparedness, and infectious-disease control strategies. [1] [2]

References

  1. Elsevier. (n.d.). Scopus author details: Min-Shi Lee, Author ID 26659600600. ScienceDirect/Scopus author profile.
    https://www.sciencedirect.com/author/26659600600/min-shi-lee
  2. National Health Research Institutes. (n.d.). Researcher: Min-Shi Lee. National Institute of Infectious Diseases and Vaccinology, Taiwan.
    https://iv.nhri.edu.tw/研究人員/李敏西/
  3. Le, T.-H.-L., Weng, T.-Y., Yen, H., Chia, M.-Y., & Lee, M.-S. (2025). Development of a novel EV-A71 monoclonal antibody for monitoring vaccine potency. PLOS Neglected Tropical Diseases, 19(6), e0013127.
    https://doi.org/10.1371/journal.pntd.0013127
  4. Chien, Y.-S., et al. (2023). Cost-effective complete genome sequencing using the MinION platform for identification of recombinant enteroviruses. Microbiology Spectrum.
    https://doi.org/10.1128/spectrum.02507-23
  5. Lin, T.-H., Chia, M.-Y., Lin, C.-Y., Yeh, Y.-Q., Jeng, U.-S., Wu, W.-G., & Lee, M.-S. (2019). Improving immunogenicity of influenza virus H7N9 recombinant hemagglutinin for vaccine development. Vaccine, 37(13), 1897–1903.
    https://doi.org/10.1016/j.vaccine.2018.09.034

Waseem Hajjar | Clinical Medicine | Innovative Research Award

Published on by Health Scientists

Innovative Research Award

Waseem Hajjar — King Saud University, Saudi Arabia

Researcher Profile
Researcher Waseem Hajjar
Affiliation King Saud University
Country Saudi Arabia
Scopus ID 35518559800
Documents 76
Citations 1,154
h-index 17
Subject Area Clinical Medicine
Event Health Scientists Awards
ORCID 0000-0001-7916-972X

Waseem Hajjar is a researcher affiliated with King Saud University, Saudi Arabia. The supplied academic profile identifies 76 documents, 1,154 citations, and an h-index of 17. His scholarly identity is additionally represented through persistent ORCID, Scopus, and Google Scholar profiles. The Innovative Research Award profile presented here summarizes the supplied bibliometric and institutional information in a neutral academic format.

Abstract

Waseem Hajjar is a clinical medicine researcher affiliated with King Saud University, Saudi Arabia, whose scholarly record includes 76 indexed documents, 1,154 citations, and an h-index of 17 according to the supplied profile data. His research portfolio reflects sustained engagement with clinical research and scholarly communication. The Innovative Research Award profile recognizes his documented research activity, publication record, citation impact, and professional presence across academic platforms. His ORCID, Scopus, and Google Scholar identifiers provide persistent links for verification and facilitate discovery of his scholarly contributions. This page summarizes the supplied academic information and presents it in a neutral format internationally.

Keywords

Clinical medicine; clinical research; medical research; healthcare research; evidence-based medicine; biomedical research; academic publishing; research collaboration; scholarly communication; research impact; citation analysis; Scopus; ORCID; Google Scholar; King Saud University; Saudi Arabia; innovative research; medical science; health sciences.

Introduction

Waseem Hajjar’s academic profile is presented within the context of clinical medicine and scholarly research. The supplied information identifies King Saud University as his institutional affiliation and Saudi Arabia as his country. Bibliometric indicators provide a concise description of indexed research activity, while persistent identifiers enable readers to distinguish and verify the researcher’s scholarly record across major academic platforms. Scopus provides author-level indexing and citation information, whereas ORCID supplies a persistent researcher identifier.

Research Profile

Waseem Hajjar is affiliated with King Saud University in Saudi Arabia and is identified in Scopus by author ID 35518559800. The supplied profile records 76 documents, 1,154 citations, and an h-index of 17. His identifiers across Scopus and ORCID support consistent attribution and scholarly profile discovery within academic databases internationally. These platforms provide complementary approaches to discovering publications, citations, author identifiers, and scholarly outputs. Bibliographic databases may differ in coverage and indexing practices, so individual records should be consulted when precise publication-level information is required. [1]

Research Contributions

Waseem Hajjar’s research contributions can be described through documented publication activity in clinical medicine and the associated citation record. Metrics indicate sustained scholarly output rather than one contribution. Interpretation of research themes should rely on individual publications, methodologies, findings, clinical contexts, and independently documented evidence from relevant literature and sources. Assessment of clinical research contributions generally requires consideration of study design, methodological rigor, reproducibility, clinical relevance, and the extent to which findings contribute to established knowledge.  [2]

Publications

Waseem Hajjar’s publication record contains 76 documents in the supplied Scopus profile. These publications provide evidence to evaluate research themes, methods, collaborations, and clinical relevance. Because publication titles and bibliographic details were not supplied here, this section avoids assigning topics and instead directs readers to the author record for verification. The supplied document count should be understood as a database-specific indicator rather than a complete inventory of every scholarly output.  [1]

Research Impact

Waseem Hajjar’s supplied citation indicators include 1,154 citations and an h-index of 17. These measures provide quantitative descriptions of scholarly visibility within the indexed record, while interpretation depends on field, publication age, database coverage, collaboration patterns, and citation practices. They should therefore be considered alongside publication-level evidence and contextual assessment. Citation indicators are commonly used to describe patterns of scholarly attention, but they have recognized limitations. [3]

Award Suitability

Waseem Hajjar’s profile contains identifiable academic credentials, indexed publications, citation indicators, and persistent researcher identifiers relevant to consideration for an Innovative Research Award. Award suitability should be determined from documented evidence, including originality, methodological quality, research contribution, reproducibility, and relevance of individual studies, rather than from bibliometric indicators alone. For a comprehensive award assessment, individual publications and supporting evidence should be reviewed alongside the supplied profile information. [4]

Conclusion

Waseem Hajjar’s supplied academic profile documents an affiliation with King Saud University, a Scopus author record containing 76 documents, 1,154 citations, and an h-index of 17, together with persistent ORCID and Google Scholar identifiers. These details provide a structured overview of scholarly activity. More detailed evaluation should be based on the underlying publications and independently verifiable research evidence.

References

  1. Elsevier. (n.d.). Scopus author details: Waseem Hajjar, Author ID 35518559800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=35518559800
  2. ORCID. (n.d.). Waseem Hajjar — ORCID record.
    https://orcid.org/0000-0001-7916-972X
  3. Kaaki, S., Barnawi, A. B., Robaidi, H. A., Maghrabi, A. A., Almaymuni, A. D., Alzahim, A., Almahmoud, A., Alsalem, K. A., Alshehri, Y. M., Alsharari, H. S., & Hajjar, W. M. (2026). Perioperative outcomes and safety of uniportal robotic-assisted thoracic surgery (U-RATS) for anatomic lung resection: A systematic review and meta-analysis. https://link.springer.com/article/10.1007/s11701-026-03349-x
  4. Health Scientists Awards. (n.d.). Health Scientists Awards.
    https://healthscientists.org/
  5. Google Scholar. (n.d.). Waseem Hajjar — Google Scholar profile.
    https://scholar.google.com/citations?user=7s7wbfUAAAAJ&hl=en&oi=ao

Hani Al-Baadani | Nutrition Science | Innovative Research Award

Published on by Health Scientists

Innovative Research Award

Hani Al-Baadani
Affiliation King Saud University
Country Saudi Arabia
Scopus ID 57185776200
Subject Area Nutrition Science
Event Health Scientists Awards
ORCID 0000-0003-3994-9216

Hani Al-Baadani is a researcher at King Saud University whose published work centers on animal production, poultry nutrition, feed additives, intestinal health, immunity, and productive performance. His studies examine nutritional interventions and biological responses in livestock and poultry, connecting diet composition with growth, health indicators, and production outcomes across systems. [1]

Abstract

Hani Al-Baadani is a researcher at King Saud University whose scholarly work focuses on animal nutrition, poultry production, feed additives, intestinal health, immunity, and productive performance. His publications investigate dietary interventions and their effects on growth, physiological indicators, oxidative status, nutrient utilization, and intestinal morphology. Research involving gum arabic, phytogenic additives, biotic supplementation, and dietary fiber illustrates an experimental approach to improving animal health and production efficiency. His work appears across peer-reviewed journals in animal science, veterinary science, and nutrition-related fields. The research profile provides a basis for academic recognition based on documented publications, research contributions, and measurable scholarly impact.

Keywords

Poultry nutrition, animal nutrition, feed additives, gut health, intestinal morphology, immune response, oxidative stress, growth performance, nutrient digestibility, rumen fermentation, phytogenic supplementation, gum arabic, biotic supplementation, dietary fiber, broiler chickens, lambs, feed evaluation, and sustainable animal production research across livestock systems and experimental nutrition studies.

Introduction

Hani Al-Baadani is a researcher at King Saud University whose published work centers on animal production, poultry nutrition, feed additives, intestinal health, immunity, and productive performance. His studies examine nutritional interventions and biological responses in livestock and poultry, connecting diet composition with growth, health indicators, and production outcomes across systems. [1]

Research Profile

Hani Al-Baadani is affiliated with the Department of Animal Production, College of Food and Agriculture Sciences, King Saud University, Saudi Arabia. Research profiles describe interests spanning poultry science, feeding, feed evaluation, animal biotechnology, milk quality, meat science, and feed additives. His publication record includes studies addressing nutritional and physiological responses. [1]

Research Contributions

Hani Al-Baadani has contributed to research on dietary supplementation, natural feed additives, gut health, immunity, oxidative status, nutrient utilization, and animal performance. Recent publications examine gum arabic, phytogenic mixtures, wild thyme, neutral detergent fiber, and nutritional interventions, providing experimental evidence concerning productive, physiological, and intestinal outcomes in livestock and poultry. [2] [3]

Publications

Hani Al-Baadani has coauthored studies in journals Poultry Science, Animals, Journal of Animal Science and Technology, Indian Journal of Animal Research, and Italian Journal of Animal Science. Publications address gum arabic supplementation, biotics, feed additives, nutrient digestibility, rumen characteristics, oxidative status, intestinal morphology, and productive performance in poultry and livestock. [2] [3] [4]

Research Impact

Hani Al-Baadani’s research contributes evidence relevant to animal nutrition and production by evaluating dietary strategies and biological responses. Reported outcomes include growth performance, immune response, oxidative status, intestinal morphology, nutrient digestibility, and feed-related traits. These studies can inform experimental research on sustainable nutrition, health management, and productivity in animal systems. [2] [4]

Award Suitability

Hani Al-Baadani’s publication activity and research focus provide a basis for consideration within a recognition program emphasizing nutrition science and animal-production research. His work demonstrates sustained engagement with dietary interventions, feed additives, animal health, and productive performance. Award assessment should independently consider verified bibliometric data, originality, contribution, and broader impact. [1]

Conclusion

Hani Al-Baadani’s scholarly work connects animal nutrition with poultry and livestock health, productivity, and physiological responses. His publications investigate dietary interventions through measurable experimental outcomes, including growth, immunity, intestinal condition, nutrient utilization, and oxidative status. The record provides a documented foundation for further research and academic evaluation within nutrition-related disciplines. [2]

References

  1. Elsevier. (n.d.). Scopus author details: Hani Al-Baadani, Author ID 57185776200. Scopus.https://www.scopus.com/authid/detail.uri?authorId=57185776200
  2. Al-Baadani, H. H., Alhotan, R. A., Al-Abdullatif, A. A., Alhidary, I. A., Alharthi, A. S., Al-Mufarrej, S. I., Al-Garadi, M. A., Qaid, M. M., Al-Sagan, A. A., Ibrahim, K. E., & Azzam, M. M. (2022). The Effect of Gum Arabic Supplementation on Growth Performance, Blood Indicators, Immune Response, Cecal Microbiota, and the Duodenal Morphology of Broiler Chickens. Animals, 12(20), 2809.https://doi.org/10.3390/ani12202809
  3. Al-Baadani, H. H., Qaid, M. M., Alharthi, A. S., et al. (2026). Dietary biotic supplementation modulates growth performance, anticoccidial efficacy, oxidative status, and intestinal histomorphology in Eimeria tenella-challenged broilers. Poultry Science, 105(8), 107112.https://doi.org/10.1016/j.psj.2026.107112
  4. Alhidary, I. A., Al-Baadani, H. H., Alharthi, A. S., & Aboragah, A. A. (2024). The Effects of Varied Neutral Detergent Fiber Levels on Blood Parameters, Nutrient Digestibility, Rumen Fermentation Characteristics and Rumen Tissue Morphology in Lambs. Indian Journal of Animal Research, 58(12), 2115–2124.https://doi.org/10.18805/IJAR.BF-1860
  5. Al-Ghamdi, S., Al-Baadani, H. H., Alharthi, A. S., Suliman, G. M., & Alhidary, I. A. (2025). Effect of adding citrus flavonoid (Bioflavex) to diet on growth performance, feed efficiency, rumen histomorphology, carcass traits and meat quality of lambs. Frontiers in Veterinary Science.https://doi.org/10.3389/fvets.2025.1572911

Sibel Ozdemir | Pharmacology | Innovative Research Award

Published on by Health Scientists

Innovative Research Award

Sibel Ozdemir — Yunus Emre State Hospital, Turkey

Sibel Ozdemir
Affiliation Yunus Emre State Hospital
Country Turkey
Scopus ID 60749146700
Subject Area Pharmacology
Event Health Scientists Awards
ORCID 0009-0003-4671-0964

Sibel Ozdemir is a researcher associated with Yunus Emre State Hospital whose recent scholarly work connects neurology with pharmacological investigation. Published studies have examined antiseizure medicines, experimental seizure models, medication combinations, and potential interactions involving clopidogrel, valproic acid, and levetiracetam. [1] [2]

Abstract

Sibel Ozdemir is a researcher affiliated with Yunus Emre State Hospital in Turkey whose documented work addresses pharmacology, neurology, and experimental seizure research. Her recent publications examine interactions between antiplatelet and antiseizure medicines and pharmacological effects in experimental models. This profile summarizes her research themes, publications, and recognition context in research.

Keywords

Epilepsy, valproic acid, levetiracetam, clopidogrel, pentylenetetrazol, freezing behavior, antiseizure medicines, anticonvulsant efficacy, experimental seizure models, behavioral effects, drug interactions, neurology, pharmacology, and clinical pharmacology. These terms reflect the themes identified in her recent research publications. [1] [2]

Introduction

Sibel Ozdemir is affiliated with the Department of Neurology at Yunus Emre State Hospital, Eskişehir, Türkiye. Her recent scholarly record includes investigations involving antiseizure medicines, drug interactions, and neurological models. These studies connect clinical neurology with pharmacological questions concerning treatment combinations and biological responses in experimental research settings. [1] [2]

Research Profile

Sibel Ozdemir’s documented research profile centers on neurology and pharmacology, with publications involving antiseizure therapy, experimental seizure models, and medication interactions. PubMed records identify her ORCID as 0009-0003-4671-0964 and associate recent work with Yunus Emre State Hospital. The available evidence supports a clinically oriented pharmacological research profile in clinical practice. [1]

Research Contributions

Sibel Ozdemir contributes to research examining pharmacological effects in neurological conditions. A 2026 study evaluated clopidogrel alongside valproic acid and levetiracetam in a pentylenetetrazol-induced seizure model, while another study examined differential effects of valproic acid and levetiracetam on freezing behavior. These studies address medication efficacy and drug interactions in pharmacology. [1] [2]

Publications

Sibel Ozdemir is listed as an author on publications concerning antiseizure pharmacology and neurological experimental models. Her 2026 International Journal of Molecular Sciences article investigated clopidogrel with valproic acid and levetiracetam, while a 2026 Journal of Biotechnology and Strategic Health Research article examined valproic acid and levetiracetam effects in rats. [1] [2]

Research Impact

Sibel Ozdemir’s research has potential relevance to pharmacological decision-making by investigating how neurological medicines behave in experimental combinations. The documented studies provide evidence about antiseizure efficacy and medication interactions, while their experimental designs also illustrate translational questions that may require further clinical investigation before broader conclusions are drawn. [1] [2]

Award Suitability

Sibel Ozdemir’s publication activity aligns with an Innovative Research Award profile through its focus on pharmacological questions in neurological research and experimental models. The publications demonstrate investigation of drug combinations and antiseizure effects. Award recognition should consider originality, methodological contribution, publication record, and relevance of the submitted research evidence overall. [1] [2]

Conclusion

Sibel Ozdemir’s available scholarly record presents a research trajectory connecting clinical neurology with pharmacology and experimental seizure research. Her recent publications provide documented evidence of work on antiseizure medicines and drug interactions. Continued publication, independent validation, and clinical translation would further clarify the broader significance of these research contributions today. [1] [2]

References

    1. Özdemir, S., Bolayır, E., & Şahin İnan, Z. D. (2026). Effects of Clopidogrel on the Anticonvulsant Efficacy of Valproic Acid and Levetiracetam in a PTZ-Induced Seizure Model. International Journal of Molecular Sciences, 27(14), 6415.
      https://doi.org/10.3390/ijms27146415
    2. Gürkan, İ. M., Demir Cevizlidere, B., Çalişkan, S., Özdemir, S., & Özdemir, H. (2026). Effects of nano-hydroxyapatite-coated PRF on gingiva-derived mesenchymal stem cells: In vitro study. International Journal of Molecular Sciences, 27(13), 5736.
      https://doi.org/10.3390/ijms27135736
    3. ORCID. (n.d.). ORCID record: Sibel Ozdemir, ORCID 0009-0003-4671-0964.
      https://orcid.org/0009-0003-4671-0964
    4. Elsevier. (n.d.). Scopus author details: Sibel Ozdemir, Author ID 60749146700. Scopus.
      https://www.scopus.com/authid/detail.uri?authorId=60749146700

Jaehoon Lee | Clinical Medicine | Innovative Research Award

Published on by Health Scientists

Innovative Research Award

Jaehoon Lee
Affiliation Clinical Medicine; vascular and endovascular surgery
Country South Korea
Google Scholar View Profile
Documents 25
Citations 155
h-index 8
Subject Area Clinical Medicine
Event Health Scientists Awards
ORCID 0000-0002-0906-5236

Jaehoon Lee is a South Korean clinician-researcher working in vascular and endovascular surgery within clinical medicine. His documented publications address peripheral arterial disease, endovascular aneurysm repair, vascular access, arterial reconstruction, and device-based interventions. His work combines clinical outcomes, procedural evaluation, imaging, and statistical analysis to examine practical vascular treatment strategies. [1]

Abstract

Jaehoon Lee is a South Korean clinical medicine researcher whose documented work focuses on vascular and endovascular surgery. His publications address endovascular aneurysm repair, peripheral arterial disease, femorofemoral bypass, arteriovenous access thrombosis, and emerging procedural approaches. The research emphasizes anatomical assessment, graft performance, procedural feasibility, postoperative complications, and clinical outcomes. His studies include retrospective analyses, case-based investigations, and multicenter prospective research, reflecting an applied approach to vascular care. The publication record demonstrates sustained interest in improving revascularization strategies, evaluating vascular devices, and identifying factors associated with treatment outcomes. These contributions support consideration for an Innovative Research Award in Clinical Medicine.

Keywords

Vascular surgery; endovascular surgery; peripheral arterial disease; endovascular aneurysm repair; abdominal aortic aneurysm; femorofemoral bypass; saphenous vein graft; polytetrafluoroethylene; vascular access; arteriovenous fistula; thrombosis; rotational atherectomy; infrainguinal arterial disease; revascularization; graft patency; iliac branch device; arterial anatomy; vascular devices; clinical outcomes; postoperative complications; predictive modeling; machine learning; atherosclerosis; clinical medicine.

Introduction

Jaehoon Lee is a South Korean clinician-researcher working in vascular and endovascular surgery within clinical medicine. His documented publications address peripheral arterial disease, endovascular aneurysm repair, vascular access, arterial reconstruction, and device-based interventions. His work combines clinical outcomes, procedural evaluation, imaging, and statistical analysis to examine practical vascular treatment strategies. [1]

Research Profile

Jaehoon Lee’s research profile centers on vascular and endovascular surgery, with publications involving abdominal aortic aneurysm repair, femorofemoral bypass, arteriovenous access, and infrainguinal arterial disease. His documented work reflects clinically oriented investigation, retrospective and multicenter study designs, procedural assessment, and evaluation of anatomical or treatment factors affecting outcomes today broadly. [2]

Research Contributions

Jaehoon Lee has contributed to clinical vascular research through studies evaluating endovascular aneurysm repair, graft selection, vascular access thrombosis, and contemporary peripheral interventions. His publications examine technical feasibility, anatomical change, graft patency, postoperative complications, and longer-term clinical outcomes, providing evidence relevant to decision-making in vascular surgery practice and patient care. [3]

Publications

Jaehoon Lee’s documented publication record includes research on changes following endovascular aneurysm repair, custom-made iliac branch devices, femorofemoral bypass graft selection, postoperative thrombosis of arteriovenous access, and predictive modeling of arteriovenous fistula occlusion. Recent multicenter research also examines rotational atherectomy with antirestenotic therapy for infrainguinal arterial disease. [1] [2]

Research Impact

Jaehoon Lee’s research has clinical relevance because vascular diseases require durable revascularization, careful anatomical assessment, and management of procedure-related complications. His studies address these needs through outcome-oriented analyses of bypass grafts, endovascular repair, dialysis access, and peripheral arterial interventions, supporting evidence-based refinement of vascular surgical and endovascular practice clinically directly. [3] [4]

Award Suitability

Jaehoon Lee demonstrates a research portfolio aligned with Innovative Research Award consideration in Clinical Medicine, particularly vascular and endovascular surgery. His documented studies investigate procedural strategies, device applications, graft alternatives, predictive modeling, and multicenter peripheral arterial treatment. The portfolio shows sustained clinical investigation and practical relevance to contemporary vascular care.[5]

Conclusion

Jaehoon Lee’s documented research demonstrates a consistent clinical focus on vascular and endovascular medicine, spanning aneurysm repair, peripheral arterial disease, bypass surgery, vascular access, and procedural innovation. The available publication record supports recognition of a clinically relevant research program that connects technical investigation with patient-centered outcomes and evolving vascular practice.[4]

References

  1. Lee JH, Park KH, Kwak SG. Changes in Neck Angle, Neck Length, Maximum Diameter, Maximum Area and Thrombus after Endovascular Aneurysm Repair. Vascular Specialist International. https://doi.org/10.5758/vsi.190054
  2. Park YE, Lee JH, Yun WS, Park KH. Surgeon custom-made iliac branch device to salvage hypogastric artery during endovascular aneurysm repair. Journal of Korean Medical Science. https://doi.org/10.3346/jkms.2014.29.12.1678
  3. Kwon G, Park KH, Kwak SG, Lee JH. The Results of Femorofemoral Bypass Using a Saphenous Vein Graft as an Alternative to PTFE Grafts. Vascular Specialist International. https://doi.org/10.5758/vsi.220060
  4. Kim J, Park K, Cho Y, Lee J. The Effects of Vasodilation Induced by Brachial Plexus Block on the Development of Postoperative Thrombosis of the Arteriovenous Access in Patients with End-Stage Renal Disease: A Retrospective Study. International Journal of Environmental Research and Public Health. https://pmc.ncbi.nlm.nih.gov/articles/PMC9690458/
  5. Lee JH, Kwak SG. Development of a Machine Learning-Based Predictive Model for Arteriovenous Fistula Occlusion After Surgery: A Retrospective Cohort Study from 2015 to 2025. Medicina. https://doi.org/10.3390/medicina61122150

Erin Murray | Pediatrics | Innovative Research Award

Published on by Health Scientists

Innovative Research Award

Erin Murray
UT Southwestern Medical Center, United States

Researcher Profile
Researcher Erin Murray
Affiliation UT Southwestern Medical Center
Country United States
Scopus ID 60784991400
Subject Area Pediatrics
Event Health Scientists Awards

Erin Murray is presented in this academic recognition profile in connection with the Innovative Research Award and a stated research affiliation with UT Southwestern Medical Center in the United States. The supplied researcher record identifies Pediatrics as the subject area and provides a Scopus Author ID for bibliographic identification and verification. [1]

Abstract

Erin Murray is identified as a researcher affiliated with UT Southwestern Medical Center in the United States, with Pediatrics specified as the principal subject area in the supplied profile. The Innovative Research Award profile highlights a research identity associated with scholarly investigation, pediatric health, clinical inquiry, and evidence-based advancement. Scopus Author ID 60784991400 provides a bibliographic identifier for distinguishing the researcher within the Scopus database. The available information does not include verified document, citation, or h-index values, nor does it provide specific publication titles or an ORCID identifier. Accordingly, this profile emphasizes documented affiliation, subject classification, and research recognition context. [2]

Keywords

Pediatrics; pediatric research; child health; clinical pediatrics; pediatric medicine; healthcare innovation; clinical research; evidence-based medicine; medical research; pediatric health outcomes; translational health research.

Introduction

Erin Murray is associated with UT Southwestern Medical Center, a major academic health institution in the United States, and is classified within Pediatrics in the supplied research record. The Scopus identifier offers a standardized route for bibliographic identification, while institutional affiliation provides context for interpreting scholarly activity and research recognition. [1] [2]

Research Profile

Erin Murray has a supplied subject classification in Pediatrics, positioning the research profile within child-focused health science and medical investigation. Such a profile may encompass clinical, developmental, preventive, diagnostic, or outcomes-oriented questions, although specific research themes should be confirmed against the researcher’s indexed publications rather than inferred solely from institutional or subject-area information. [2]

Research Contributions

Erin Murray is represented in this recognition profile through a documented Scopus identity and pediatric subject classification. Research contributions in this field are generally assessed through methodological quality, clinical relevance, reproducibility, interdisciplinary collaboration, and potential contribution to child health. Specific contributions require examination of verified publications, abstracts, citation records, and associated research outputs.

Publications

Erin Murray has a Scopus Author ID of 60784991400, but individual publication titles, journals, years, citation counts, and DOI identifiers were not included in the supplied dataset. Consequently, no publication-specific bibliographic claims are assigned here. The accompanying keyword set reflects the documented Pediatrics subject area and should be refined using verified publication titles from the author record. [1]

Research Impact

Erin Murray can be evaluated for research impact through bibliometric indicators, publication quality, citation performance, collaboration patterns, and demonstrated relevance to pediatric health. Because documents, citations, and h-index values were not supplied, this profile does not assign quantitative impact scores. Verification through the Scopus record is appropriate before publishing numerical performance claims.

Award Suitability

Erin Murray is presented as a candidate associated with the Innovative Research Award through the Health Scientists Awards event. The documented Pediatrics specialization and academic medical affiliation provide a relevant disciplinary context for recognition. Final suitability should be determined using the award program’s official criteria, submitted evidence, publication record, and independent evaluation procedures. [2]

Conclusion

Erin Murray is documented in the supplied information as a researcher affiliated with UT Southwestern Medical Center and working within the broad field of Pediatrics. The Scopus Author ID establishes a useful bibliographic reference point, while the Innovative Research Award provides a recognition context. Further evaluation should rely on verified publications, metrics, and research evidence.

References

  1. Elsevier. (n.d.). Scopus author details: Erin Murray, Author ID 60784991400. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=60784991400
  2. Murray, E. T., Hook, J. S., Patel, P., Xie, L., & Moreland, J. (n.d.). Differential regulation of neutrophil elastase release vs. NET generation after cardiopulmonary bypass. https://doi.org/10.3390/ijms27156634
  3. Health Scientists Awards. (n.d.). Health Scientists Awards. Official award website.
    https://healthscientists.org/

Sobhy Sallam | Nutrition Science | Innovative Research Award

Published on by Health Scientists

 

Innovative Research Award

Sobhy Sallam
Qassim University, Saudi Arabia

Sobhy Sallam
Affiliation Qassim University
Country Saudi Arabia
Scopus ID 7003381935
Documents 90
Citations 1,674
h-index 26
Subject Area Nutrition Science
Event Health Scientists Awards
ORCID 0000-0002-6949-2387

Sobhy Sallam is an academic researcher affiliated with Qassim University in Saudi Arabia, with scholarly work centered on animal nutrition, feed evaluation, ruminal fermentation, methane mitigation, and livestock productivity. His publication portfolio encompasses dietary supplements, phytogenic compounds, trace minerals, natural zeolites, forage resources, and alternative feed ingredients. The reported bibliometric profile provides a basis for examining his research activity, publication themes, scientific contributions, and suitability for recognition in an innovative research context.

Abstract

Sobhy Sallam is an academic researcher affiliated with Qassim University in Saudi Arabia, whose scholarly work centers on animal nutrition, feed evaluation, ruminal fermentation, methane mitigation, and livestock productivity. His publications examine dietary supplements, phytogenic compounds, trace minerals, natural zeolites, forage resources, and alternative feed ingredients, connecting nutritional interventions with digestibility, animal performance, metabolic responses, and environmental outcomes. His Scopus record, as supplied for this recognition profile, comprises 90 documents, 1,674 citations, and an h-index of 26. His research portfolio reflects sustained international collaboration and applied nutritional science relevant to sustainable livestock production, animal health, and contemporary production systems globally.[5]

Keywords

Animal nutrition, feed additives, ruminal fermentation, nutrient digestibility, methane mitigation, phytogenic compounds, essential oils, condensed tannins, Leucaena, zeolites, trace elements, alternative feed resources, livestock productivity, antioxidant status, immune response, rumen microbiology, forage utilization, and sustainable livestock production.

Introduction

Sobhy Sallam conducts research at the intersection of animal nutrition, feed science, rumen function, and sustainable livestock production. His publications investigate dietary additives, plant extracts, trace elements, forage resources, ruminal fermentation, nutrient digestibility, and methane mitigation. These themes connect nutrition with productivity, animal health, and efficiency in modern livestock production. Representative studies have examined dietary interventions and their effects on fermentation, digestibility, animal performance, and environmental indicators. [2] [3]

Research Profile

Sobhy Sallam’s research profile is characterized by experimental studies evaluating how diets and bioactive feed components influence nutrient utilization, rumen processes, growth, carcass traits, immunity, and metabolic indicators. Published work spans sheep, goats, rabbits, cattle, buffaloes, camels, and calves, demonstrating a broad animal-production perspective and emphasis on measurable nutritional responses. [2] [4]

Research Contributions

Sobhy Sallam has contributed to research on phytogenic additives, essential oils, tannins, zeolites, nano-materials, trace elements, alternative feed resources, and dietary energy sources. His studies have addressed ruminal methane formation, fermentation, nutrient degradability, antioxidant status, immune responses, reproductive performance, and productive efficiency, supporting evidence-based development of sustainable livestock feeding strategies. [3]

Publications

Sobhy Sallam’s publications demonstrate a sustained focus on applied animal nutrition and feed biotechnology. Representative studies address essential oils and methane emission, condensed tannins and Leucaena, natural or nano-zeolites, lemongrass extract supplementation, forage digestibility, and urea-based diets. Recent work examines alternative feed resources, trace elements, plant-derived interventions, and rumen processes. [2] [3]

Research Impact

Sobhy Sallam’s research impact can be considered through the breadth of topics addressed, cross-institutional collaboration, and citation activity associated with his scholarly record. The supplied profile reports 1,674 citations and an h-index of 26. His studies contribute evidence concerning nutritional efficiency, methane mitigation, animal performance, and feed-resource utilization in livestock. The publication record also indicates engagement with emerging approaches involving plant-derived materials, mineral supplementation, alternative feeds, and rumen-focused interventions. [1]

Award Suitability

Sobhy Sallam’s research portfolio provides a relevant scholarly basis for consideration under an innovative research award in health and agricultural sciences. His work integrates animal nutrition with environmental sustainability, feed innovation, rumen microbiology, and livestock productivity. The evidence supports recognition of sustained research activity, interdisciplinary collaboration, and practical relevance to animal-production challenges applied. [4]

Conclusion

Sobhy Sallam represents an active researcher in animal nutrition and livestock research, with publications spanning feed additives, rumen fermentation, nutrient utilization, methane mitigation, animal performance, and emerging nutritional technologies. His reported bibliometric indicators, international collaborations, and continuing publication activity provide a coherent basis for academic recognition within nutrition-focused research contexts. [4]

References

  1. Elsevier. (n.d.). Scopus author details: Sobhy Mohamed Abdallah Hassan Sallam, Author ID 7003381935. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7003381935
  2. Sallam, S. M. A., Abo-Zeid, H. M., Abaza, M. A., & El-Zaiat, H. M. (2022). Nutrient intake, digestibility, growth performance, and carcass of sheep fed urea-based diet supplemented with natural clinoptilolite. Animal Science Journal, 93(1), e13689.
    https://doi.org/10.1111/asj.13689
  3. Sallam, S. M. A., et al. (2011). Effect of some essential oils on in vitro methane emission. Archives of Animal Nutrition, 65(3), 203–214.
    https://doi.org/10.1080/1745039X.2011.568275
  4. Khattab, I. M., Abdel-Wahed, A. M., Anele, U. Y., Sallam, S., & El-Zaiat, H. M. (2023). Comparative digestibility and rumen fermentation of camels and sheep fed different forage sources. Animal Biotechnology, 34(3), 609–618.
    https://doi.org/10.1080/10495398.2021.1990939
  5. Sallam, S. M. A., Attia, M. F. A., Nour El-Din, A. N. M., et al. (2018). Involvement of Quebracho tannins in diet alters productive and reproductive efficiency of postpartum buffalo cows. Animal Nutrition, 5(1), 80–86.
    https://doi.org/10.1016/j.aninu.2018.08.003

Yun Sang Cho | Infectious Diseases | Innovative Research Award

Published on by Health Scientists

Innovative Research Award

Yun Sang Cho
Animal and Plant Quarantine Agency, South Korea
Yun Sang Cho
Affiliation Animal and Plant Quarantine Agency
Country South Korea
Scopus ID 16066666200
Documents 77
Citations 840
h-index 16
Subject Area Infectious Diseases
Event Health Scientists Awards
ORCID 0000-0003-1346-7067

Yun Sang Cho is affiliated with the Animal and Plant Quarantine Agency in South Korea and works in infectious disease research spanning veterinary health, surveillance, diagnostics, and zoonotic risk. His publications address pathogens, vectors, honeybee diseases, equine infections, and One Health preparedness, linking laboratory evidence with disease prevention and monitoring. [4]

Abstract

Yun Sang Cho is a South Korean researcher affiliated with the Animal and Plant Quarantine Agency, whose work addresses infectious diseases affecting animals, vectors, and public health. His publication record includes studies of honeybee pathogens and mites, Coxiella burnetii detection, equine piroplasmosis, and zoonotic disease preparedness. These themes connect veterinary surveillance with diagnostic methods and One Health practice. His research demonstrates applied relevance to infectious disease monitoring, laboratory investigation, epidemiological assessment, and prevention. The documented scholarly profile reports 77 documents, 840 citations, and an h-index of 16, providing quantitative context for consideration under an Innovative Research Award recognition framework. research.[5]

Keywords

Infectious diseases, zoonoses, One Health, honeybee diseases, Lake Sinai virus, Varroa mites, Tropilaelaps mites, Coxiella burnetii, Q fever, equine piroplasmosis, tick-borne diseases, molecular surveillance, serological surveillance, pathogen detection, diagnostic assays, veterinary epidemiology, animal health, disease preparedness, infectious disease surveillance, public health.

Introduction

Yun Sang Cho is affiliated with the Animal and Plant Quarantine Agency in South Korea and works in infectious disease research spanning veterinary health, surveillance, diagnostics, and zoonotic risk. His publications address pathogens, vectors, honeybee diseases, equine infections, and One Health preparedness, linking laboratory evidence with disease prevention and monitoring. [1]

Research Profile

Yun Sang Cho’s research profile reflects applied infectious disease investigation across animal health and public health interfaces. Published work includes molecular and serological surveillance, pathogen detection, diagnostic assay development, honeybee disease studies, and assessments of zoonotic threats. This portfolio demonstrates an emphasis on evidence generation for surveillance, diagnosis, and prevention. [2] [3]

Research Contributions

Yun Sang Cho has contributed to research on Coxiella burnetii detection, equine piroplasmosis surveillance, honeybee mite and viral disease monitoring, and zoonotic Q fever preparedness. His studies combine field sampling, molecular methods, serology, and epidemiological interpretation, supporting effective preventive approaches to infectious disease detection, surveillance, and coordinated One Health responses. [3] [4]

Publications

Yun Sang Cho has published research concerning Lake Sinai virus in honeybees, Varroa and Tropilaelaps mite prevalence, Coxiella burnetii detection, and equine piroplasmosis. Representative publications show recurring interests in pathogen surveillance and diagnostic technologies, with studies appearing in PLOS ONE, Journal of Apicultural Research, Parasites & Vectors, and veterinary literature. [2] [3]

Research Impact

Yun Sang Cho’s research impact can be considered through both bibliometric indicators and applied relevance. The supplied profile records 77 documents, 840 citations, and an h-index of 16. His publications address infectious disease surveillance and diagnostics with implications for animal health, zoonotic preparedness, vector management, and One Health policy development. [1] [5]

Award Suitability

Yun Sang Cho’s documented research portfolio provides a basis for consideration for an Innovative Research Award within the Health Scientists Awards framework. His work demonstrates engagement with infectious disease surveillance, diagnostic development, vector and pathogen research, and zoonotic preparedness. Final award decisions should follow transparent criteria and evaluation of evidence. [1]

Conclusion

Yun Sang Cho represents an applied infectious disease research profile centered on animal health, surveillance, diagnostics, and zoonotic preparedness. His publication themes connect laboratory investigation with field monitoring and One Health priorities. The supplied bibliometric indicators and documented studies together provide a basis for recognition, while independent assessment remains appropriate.[5]

References

  1. Elsevier. (n.d.). Scopus author details: Yun Sang Cho, Author ID 16066666200. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=16066666200
  2. Nguyen, T.-T., Yoo, M.-S., Truong, A.-T., Youn, S.-Y., Kim, D.-H., Lee, S.-J., Yoon, S.-S., & Cho, Y. S. (2024). Prevalence and genome features of Lake Sinai virus isolated from Apis mellifera in the Republic of Korea. PLOS ONE, 19(3), e0299558. https://doi.org/10.1371/journal.pone.0299558
  3. Cho, Y. S., et al. (2022). Prevalence and pathogen detection of Varroa and Tropilaelaps mites in Apis mellifera apiaries in South Korea. Journal of Apicultural Research, 62(4), 804–812. https://doi.org/10.1080/00218839.2021.2013425
  4. Truong, A.-T., Yun, B.-R., Lim, J., Min, S., Yoo, M.-S., Yoon, S.-S., Yun, Y.-M., Kim, J.-T., & Cho, Y. S. (2021). Real-time PCR biochip for on-site detection of Coxiella burnetii in ticks. Parasites & Vectors, 14, 239. https://doi.org/10.1186/s13071-021-04744-z
  5. Heo, J. Y., Cho, Y. S., Park, J. H., et al. (2023). Current Status of Q Fever and the Challenge of Outbreak Preparedness in Korea: One Health Approach to Zoonoses. Journal of Korean Medical Science, 38(24), e197. https://doi.org/10.3346/jkms.2023.38.e197

Dimitrios Tsiftsis | Public Health | Innovative Research Award

Published on by Health Scientists

Innovative Research Award

Dimitrios Tsiftsis — Nikaia General Hospital, Greece

Dimitrios Tsiftsis
Affiliation Nikaia General Hospital
Country Greece
Scopus ID 57217741199
Documents 13
Citations 91
h-index 4
Subject Area Public Health
Event Health Scientists Awards

Dimitrios Tsiftsis is a physician and researcher affiliated with the Emergency Department of Nikaia General Hospital in Greece, whose published work addresses emergency medicine, healthcare organization, acute stroke assessment, triage, and preparedness. His research record includes peer-reviewed studies examining practical approaches to improving emergency-care delivery and clinical decision-making. [1] [2]

Abstract

Dimitrios Tsiftsis is a Greek physician and researcher whose scholarly work focuses on emergency medicine, public health, triage, acute stroke assessment, healthcare organization, and emergency-care preparedness. His publications examine practical approaches to improving patient assessment, service delivery, clinical efficiency, and professional development within emergency departments. Research involving point-of-care stroke assessment and multilayer triage reflects an interest in translating operational challenges into structured clinical solutions. His contributions to discussions concerning emergency medicine in Greece further address workforce development, system organization, and healthcare quality. Collectively, these activities provide an academic basis for consideration within an Innovative Research Award framework. [1] [2]

Keywords

Emergency medicine, emergency department, public health, triage, stroke detection, point-of-care testing, healthcare organization, emergency care, clinical decision-making, patient assessment, overcrowding, healthcare quality, emergency preparedness, workforce development, medical devices, stroke, acute care, Greece, health systems, clinical innovation, multidisciplinary care, service efficiency, patient safety, healthcare delivery, professional training.

Introduction

Dimitrios Tsiftsis has contributed to scholarly discussions surrounding emergency medicine and healthcare delivery in Greece. His research addresses clinical and organizational challenges encountered in emergency departments, including triage, stroke assessment, workforce preparation, and system development. These subjects connect clinical practice with broader public health and health-service considerations. [2] [3]

Research Profile

Dimitrios Tsiftsis develops research around emergency-care systems and clinical processes, with particular attention to how emergency departments can respond to increasing patient demands. Published work identifies interests in triage design, point-of-care technologies, stroke evaluation, emergency medicine education, and healthcare organization. His affiliation with Nikaia General Hospital provides a clinical setting closely aligned with these research themes. [1] [2]

Research Contributions

Dimitrios Tsiftsis has contributed to research examining practical improvements in emergency-department performance. His work on point-of-care stroke assessment evaluates the feasibility of bedside technology, while his triage research proposes a multilayer approach to managing emergency presentations. Related scholarship addresses emergency medicine development in Greece and the preparedness of physicians working in emergency departments. [4]

Publications

Dimitrios Tsiftsis also co-authored The state of emergency medicine in Greece: at critical momentum, published in the International Journal of Emergency Medicine, which examined the development and organization of emergency medicine in Greece. His later publication, Adult Triage in the Emergency Department: Introducing a Multi-Layer Triage System, addressed restructuring triage processes in response to emergency-department workload and overcrowding. [2] [3]

Research Impact

Dimitrios Tsiftsis contributes to an area of research with direct relevance to patient flow, emergency assessment, clinical efficiency, and health-system preparedness. His publications provide evidence-based discussion of technologies and organizational models that may support emergency-care practice. The combination of clinical investigation and health-system analysis strengthens the practical relevance of his scholarly profile. [2]

Award Suitability

Dimitrios Tsiftsis presents a research profile relevant to an Innovative Research Award because his publications investigate applied solutions to recognized challenges in emergency healthcare. His studies of point-of-care stroke assessment, multilayer triage, and emergency-medicine development demonstrate an emphasis on clinically relevant innovation, service improvement, and evidence-informed healthcare practice within contemporary emergency settings. [3]

Conclusion

Dimitrios Tsiftsis has developed a scholarly profile centered on emergency medicine, public health, clinical innovation, and healthcare-system improvement. His published research addresses stroke assessment, triage, emergency-department organization, and professional readiness. These contributions provide a coherent basis for academic recognition focused on innovative approaches to improving emergency healthcare delivery and patient-centered clinical practice. [1]

References

  1. Tsiftsis, D., Manioti, E. A., Touris, G., Kyriakakis, E., Tsamopoulos, N., & Gamvroudi, M. (2024). Detecting Stroke at the Emergency Department by a Point of Care Device: A Multicenter Feasibility Study. Medical Devices: Evidence and Research, 17, 107–112.https://doi.org/10.2147/MDER.S445075
  2. Tsiftsis, D., Ulrich, A., Notas, G., Patrikakou, A., & Reid, E. (2024). The state of emergency medicine in Greece: at critical momentum. International Journal of Emergency Medicine, 17, 46.https://doi.org/10.1186/s12245-024-00622-4
  3. Tsiftsis, D., Tasioulis, A., & Bampalis, D. (2025). Adult Triage in the Emergency Department: Introducing a Multi-Layer Triage System. Healthcare, 13(9), 1070.https://doi.org/10.3390/healthcare13091070
  4. Health Scientists Awards. (n.d.). Official Award Website. https://healthscientists.org/
  5. Elsevier. (n.d.). Scopus author details: Dimitrios Tsiftsis, Author ID 57217741199. Scopus.https://www.scopus.com/pages/authors/57217741199

 

Ipeleng Kgosiemang-Xaba | Oncology | Innovative Research Award

Published on by Health Scientists

Innovative Research Award

Ipeleng Kgosiemang-Xaba
University of the Free State, South Africa
Ipeleng Kgosiemang-Xaba
Affiliation University of the Free State
Country South Africa
Scopus ID 56707418000
Documents 9
Citations 241
h-index 7
Subject Area Oncology
Event Health Scientists Awards

Ipeleng Kgosiemang-Xaba is presented in this academic recognition profile as a researcher associated with oncology and biomedical research at the University of the Free State in South Africa. Her scholarly work includes investigations of Euphorbia species, phytochemicals, antiproliferative activity, nanomaterials, and cancer-related applications. Publications identify research examining plant-derived compounds, toxicity, pharmacological properties, and nanoparticle-based approaches against breast cancer models. This work connects natural-product research with experimental oncology and drug-discovery questions.[1]

Abstract

Ipeleng Kgosiemang-Xaba is presented in this recognition profile as a researcher associated with oncology and biomedical research at the University of the Free State in South Africa. Her scholarly work includes investigations of Euphorbia species, phytochemicals, antiproliferative activity, nanomaterials, and cancer-related applications. Publications identify research examining plant-derived compounds, toxicity, pharmacological properties, and nanoparticle-based approaches against breast cancer models. This work connects natural-product research with experimental oncology and drug-discovery questions. The profile therefore highlights an interdisciplinary trajectory centered on biologically active South African plants, cancer-related mechanisms, and translational opportunities while maintaining a neutral distinction between documented scientific outputs and award recognition.[3]

Keywords

Euphorbia species; cancer; medicinal plants; pharmacological properties; toxicity; secondary metabolites; breast cancer; antiproliferative activity; iron oxide nanoparticles; iron dioxide nanoparticles; natural-product pharmacology; phytochemicals. These terms are aligned particularly with the publication literature addressing Southern African Euphorbia species and experimental anticancer research.[2]

Introduction

Ipeleng Kgosiemang-Xaba’s research profile reflects an interdisciplinary interest in oncology, medicinal plants, pharmacology, and biomedical technology. Her publications address Euphorbia-derived bioactive compounds and experimental anticancer approaches, including nanoparticle systems evaluated against breast cancer cell lines. These themes place natural-product research within a framework of cancer research and translational biomedical investigation.[1]

Research Profile

Ipeleng Kgosiemang-Xaba has published work spanning molecular biology, medicinal plants, phytochemistry, pharmacology, and oncology. Her research includes studies of Euphorbia species and their secondary metabolites, together with experimental investigations of antiproliferative effects and nanoparticle-mediated approaches. The available literature indicates a continuing interest in linking biological resources with therapeutic research questions.[2][3]

Research Contributions

Ipeleng Kgosiemang-Xaba’s contributions include systematic examination of Southern African Euphorbia species, their medicinal uses, toxicity, phytochemical constituents, and reported pharmacological activities. Her research also includes green synthesis of iron-based nanoparticles using Euphorbia tirucalli and evaluation of antiproliferative activity against breast cancer cell lines, thereby connecting plant science with experimental oncology.[2][3]

Publications

Ipeleng Kgosiemang-Xaba is associated with publications addressing Euphorbia pharmacology, anticancer research, nanoparticle synthesis, and molecular biology. A 2025 review in Plants examined medicinal uses, toxicity, secondary metabolites, and pharmacological properties of Southern African Euphorbia species, while a 2023 Journal of Experimental Nanoscience article evaluated iron-based nanoparticles and breast cancer models.[5]

Research Impact

Ipeleng Kgosiemang-Xaba’s research impact can be considered through the relevance of her publications to natural-product pharmacology, cancer biology, and biomedical nanotechnology. Her work contributes evidence on underexplored Southern African plant resources and experimental anticancer strategies. Citation activity and publication visibility provide measurable indicators, while broader clinical significance requires further validation.[3]

Award Suitability

Ipeleng Kgosiemang-Xaba’s documented research themes are compatible with an Innovative Research Award focused on oncology, natural-product discovery, and biomedical technology. Her publications demonstrate research activity involving anticancer constituents, Euphorbia species, phytochemicals, and nanoparticle systems. Award suitability should remain subject to the event’s published formal criteria, independent verification, and comparative assessment.[4]

Conclusion

Ipeleng Kgosiemang-Xaba presents a research profile connecting Southern African medicinal plants with pharmacology, nanotechnology, and oncology. Her publications provide evidence of work on Euphorbia chemistry, toxicity, antiproliferative activity, and cancer-oriented experimental systems. Collectively, these outputs support recognition of an emerging interdisciplinary research direction without implying clinical efficacy beyond published evidence.[2]

References

  1. Elsevier. (n.d.). Scopus author details: Ipeleng Kgosiemang-Xaba, Author ID 56707418000. Scopus.https://www.scopus.com/authid/detail.uri?authorId=56707418000
  2. Kgosiemang, I. K. R., Lefojane, R., Adegoke, A. M., Ogunyemi, O., Mashele, S. S., & Sekhoacha, M. P. (2025). Pharmacological significance, medicinal use, and toxicity of extracted and isolated compounds from Euphorbia species found in Southern Africa: A review. Plants, 14(3), 469.https://doi.org/10.3390/plants14030469
  3. Kgosiemang, I. K. R., Adegoke, A. M., Mashele, S. S., & Sekhoacha, M. P. (2023). Green synthesis of iron oxide and iron dioxide nanoparticles using Euphorbia tirucalli: Characterization and antiproliferative evaluation against three breast cancer cell lines. Journal of Experimental Nanoscience, 18(1), 2276276.https://doi.org/10.1080/17458080.2023.2276276
  4. Parvez, M., Qhanya, L. B., Mthakathi, N. T., Kgosiemang, I. K. R., et al. (2016). Molecular evolutionary dynamics of cytochrome P450 monooxygenases across kingdoms: Special focus on mycobacterial P450s. Scientific Reports, 6, 33099.https://doi.org/10.1038/srep33099
  5. Kgosiemang, I. K. R. (2024). Targeted delivery of iron, cobalt and magnesium nanoparticles incorporating anticancer constituents of Euphorbia species for treatment of breast cancer. Doctor of Health Sciences in Biomedical Technology, Central University of Technology, Free State.https://cutscholar.cut.ac.za/items/e527142e-a8dc-4c94-8eb1-121facf1eff7/full